Cite
Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
MLA
Bever, Alaina M., et al. “Metabolomic Signatures of Inflammation and Metabolic Dysregulation in Relation to Colorectal Cancer Risk.” Journal of the National Cancer Institute, vol. 116, no. 7, July 2024, pp. 1126–36. EBSCOhost, https://doi.org/10.1093/jnci/djae047.
APA
Bever, A. M., Hang, D., Lee, D. H., Tabung, F. K., Ugai, T., Ogino, S., Meyerhardt, J. A., Chan, A. T., Eliassen, A. H., Liang, L., Stampfer, M. J., & Song, M. (2024). Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk. Journal of the National Cancer Institute, 116(7), 1126–1136. https://doi.org/10.1093/jnci/djae047
Chicago
Bever, Alaina M, Dong Hang, Dong Hoon Lee, Fred K Tabung, Tomotaka Ugai, Shuji Ogino, Jeffrey A Meyerhardt, et al. 2024. “Metabolomic Signatures of Inflammation and Metabolic Dysregulation in Relation to Colorectal Cancer Risk.” Journal of the National Cancer Institute 116 (7): 1126–36. doi:10.1093/jnci/djae047.